Carbidopa IR Pellets Manufacturer in India

Carbidopa IR Pellets Manufacturer in India

Pharmaceutical-Grade Carbidopa IR Pellets for Immediate-Release Oral Formulations

Carbidopa IR Pellets are multiparticulate pharmaceutical formulations designed for immediate-release oral dosage applications. Carbidopa is identified by CAS Number 28860-95-9, with molecular formula C₁₀H₁₄N₂O₄ and molecular weight 226.23 g/mol for the anhydrous form. Carbidopa is also commercially encountered as the monohydrate, which has CAS Number 38821-49-7 and molecular weight 244.24 g/mol.

The SDP pellet product list specifies Carbidopa IR Pellets at 12.50% strength. This provides a defined active-loading option for pharmaceutical manufacturers developing immediate-release multiparticulate formulations.

The IR pellet format is designed to provide an immediate-release profile from the multiparticulate system. Finished-pellet performance depends on the formulation composition, active loading, pellet characteristics and applicable release specification.

Key Features

• Carbidopa immediate-release pharmaceutical pellets
• 12.50% active loading
• Pharmaceutical-grade multiparticulate formulation
• Immediate-release formulation platform
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Defined active ingredient loading
• Product-specific quality parameters
• Formulation flexibility for pharmaceutical manufacturers
• Suitable for bulk pharmaceutical requirements

Product Information

Carbidopa is a chiral pharmaceutical ingredient. The anhydrous form has the molecular formula C₁₀H₁₄N₂O₄ and molecular weight 226.23 g/mol. The monohydrate form has the formula C₁₀H₁₆N₂O₅ and molecular weight 244.24 g/mol.

For Carbidopa IR Pellets, the active ingredient is incorporated into a multiparticulate pellet system intended for immediate-release formulation applications. The 12.50% value represents the pellet active loading and should not be confused with the purity specification of the Carbidopa raw material.

Available Strength

Carbidopa IR Pellets — 12.50%

The 12.50% strength is listed in the SDP pellet product catalogue.

Applications

Carbidopa IR Pellets can be considered for:

• Immediate-release oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Carbidopa IR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 12.50% Strength: Defined active-loading option for formulation development. 
• Immediate-Release Format: Designed for immediate-release multiparticulate applications.
• Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
• Product-Specific Quality Control: Finished pellets can be evaluated against defined product specifications.
• Capsule-Filling Applications: Suitable for formulations using multiparticulate capsule filling.
• Bulk Pharmaceutical Supply: Suitable for commercial formulation requirements.

Packaging & Supply

Carbidopa IR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp